カテゴリ： GlobalData, アメリカ, 企業調査

Quest Diagnostics Inc (DGX)-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：Quest Diagnostics Inc (DGX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8014252
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月22日
◆ページ数：74
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, life insurer services, clinical trial testing, healthcare information technology. It also provides diagnostic products. The company offers these services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories and governmental agencies. Diagnostics, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. The company is headquartered in Madison, New Jersey, the US.

Quest Diagnostics Inc (DGX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Partnerships 20
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
Licensing Agreements 25
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Debt Offering 26
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Asset Transactions 38
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Acquisition 39
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc – Key Competitors 48
Quest Diagnostics Inc – Key Employees 49
Quest Diagnostics Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Joint Venture 53
Recent Developments 54
Financial Announcements 54
Oct 19, 2017: Quest Diagnostics Reports Third Quarter 2017 Financial Results 54
Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook 55
Apr 20, 2017: Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook 56
Jan 26, 2017: Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017 57
Nov 11, 2016: Quest Diagnostics Raises Revenue Growth Outlook, Increases Dividend at 2016 Investor Day 58
Oct 20, 2016: Quest Diagnostics Reports Third Quarter 2016 Financial Results 59
Jul 21, 2016: Quest Diagnostics Reports Second Quarter 2016 Financial Results 61
Apr 21, 2016: Quest Diagnostics Reports First Quarter 2016 Financial Results 63
Jan 28, 2016: Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For Full Year 2016; Increases Dividend 5% To $0.40 Per Quarter 64
Corporate Communications 65
Mar 06, 2017: Quest Diagnostics and American Diabetes Association to Help Identify People at Risk for Type 2 Diabetes 65
Dec 15, 2016: Quest Diagnostics Board of Directors Elects Stephen H. Rusckowski Chairman of the Board 66
Legal and Regulatory 67
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 67
Government and Public Interest 68
Nov 20, 2017: Quest Diagnostics Provides Update on Impact of Final 2018 Medicare Payment Rates for Clinical Laboratory Tests 68
Sep 06, 2017: Half of Americans Tested Misuse Their Prescription Medications, According to Quest Diagnostics Analysis 69
Other Significant Developments 71
Sep 27, 2017: Quest Diagnostics Provides Update On Impact to Third Quarter Financial Results from Hurricanes 71
Oct 18, 2016: IBM and Quest Diagnostics Launch Watson-Powered Genomic Sequencing Service to Help Physicians Bring Precision Cancer Treatments to Patients Nationwide 72
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74

List of Tables
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Quest Diagnostics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Quest Diagnostics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Quest Diagnostics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Quest Diagnostics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Quest Diagnostics Acquires Lab Outreach Service Business of Clinical Laboratory Partners 13
Quest Diagnostics Acquires Lab Outreach Service Business from Memorial Care Health System 14
Quest Diagnostics Acquires Outreach Laboratory Service Operations from Steward Health Care System 15
Quest Diagnostics Completes Acquisition Of Lab-Related Clinical Outreach Operations Of Dignity Health 16
Quest Diagnostics Acquires Advanced Toxicology Network Lab Business Of Concentra Operating 18
Quest Diagnostics Completes Acquisition Of Clinical Outreach Lab Business Of UMass Memorial Medical Center 19
Augurex Life Sciences Enters Into Licensing Agreement With Quest Diagnostics For 14-3-3n Biomarker 20
Quintiles to Form Joint Venture with Quest Diagnostics 22
Genomic Vision Extends Co-Development Agreement With Quest Diagnostics 23
Quest Diagnostics Enters Into Collaboration With Genomic Vision 24
TrovaGene Enters Into Licensing Agreement With Quest Diagnostics For NPM1 Marker 25
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2020 26
Quest Diagnostics Raises USD600 Million in Public Offering of Senior Notes Due 2025 28
Quest Diagnostics Raises USD300 Million in Public Offering of Senior Notes Due 2045 30
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2019 For US$300 Million 32
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2024 For US$300 Million 33
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2040 For US$200 Million 34
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2014 For US$200 Million 35
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2016 For US$300 Million 36
Quest Diagnostics Completes Public Offering Of Senior Notes Due 2021 For US$550 Million 37
Royalty Pharma Acquires Ibrutinib Royalty Rights From Quest Diagnostics For US$485 Million 38
Quest Diagnostics May Sell itself 39
Quest Diagnostics Completes Acquisition Of Summit Health, Prevention And Wellness Service Provider 40
Quest Diagnostics Completes Acquisition Of Solstas Lab Partners From Welsh, Carson, Anderson & Stowe For US$570 Million 41
Quest Diagnostics Acquires ConVerge Diagnostic Services From Water Street Healthcare 42
Quest Diagnostics Completes Acquisition Of S.E.D. Medical Labs From Lovelace Health 43
Quest Diagnostics Completes Acquisition Of Celera 44
Quest Diagnostics Completes Acquisition Of Athena Diagnostics 46
Quest Diagnostics Inc, Key Competitors 48
Quest Diagnostics Inc, Key Employees 49
Quest Diagnostics Inc, Subsidiaries 51
Quest Diagnostics Inc, Joint Venture 53

★海外企業調査レポート[Quest Diagnostics Inc (DGX)-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Delcath Systems Inc (DCTH)：医療機器：M&Aディール及び事業提携情報
    Summary Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloods …
  • FAR Ltd (FAR)：石油・ガス：M&Aディール及び事業提携情報
    Summary FAR Ltd (FAR), formerly First Australian Resources NL, is an independent oil and gas company that offers acquisition, exploration, production and development of oil and natural gas properties. The company has oilfield appraisal wells and exploration assets in West and East Africa. It operate …
  • Semtech Corp (SMTC)：企業の財務・戦略的SWOT分析
    Summary Semtech Corp (Semtech) operates as a supplier of analog and mixed-signal semiconductor products. The company provides products such as isolated power switches, UHD-SDI gearbox, wireless charging ICs, battery chargers, cable drivers, capacitive touch controllers, charge pump and current sink …
  • 23andMe Inc-医療機器分野：企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • Snyder’s-Lance Inc：企業の戦略的SWOT分析
    Snyder's-Lance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Lake Region Electric Cooperative, Inc.：発電所・企業SWOT分析
    Lake Region Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Genzyme Corp：企業の戦略的SWOT分析
    Genzyme Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Advanced Proteome Therapeutics Corp (APC)：企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Disproquima S.A.：企業の戦略・SWOT・財務情報
    Disproquima S.A. - Strategy, SWOT and Corporate Finance Report Summary Disproquima S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Starkey Hearing Technologies Inc：企業の戦略的SWOT分析
    Starkey Hearing Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • GenMark Diagnostics Inc (GNMK)：企業の製品パイプライン分析2018
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Brainsway Ltd (BRIN)：医療機器：M&Aディール及び事業提携情報
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Eagle Energy Inc (EGL)：石油・ガス：M&Aディール及び事業提携情報
    Summary Eagle Energy Inc (Eagle) is an oil and gas company that acquires for, develops and produces oil and gas reserves through its subsidiaries. It focuses on the acquisition and exploitation of conventional long-life hydrocarbon reserves in on-shore production basins in North America. It acquires …
  • Total SA (FP)：電力：M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …
  • Total Produce plc：企業の戦略・SWOT・財務分析
    Total Produce plc - Strategy, SWOT and Corporate Finance Report Summary Total Produce plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Brookfield Property REIT Inc (BPYU)：企業の財務・戦略的SWOT分析
    Brookfield Property REIT Inc (BPYU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • NovoCure Ltd (NVCR)：企業の製品パイプライン分析2018
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Antisense Therapeutics Ltd (ANP)：企業の財務・戦略的SWOT分析
    Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Astute Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Astute Medical Inc (Astute Medical), a subsidiary of BioMerieux SA is a diagnostic equipment provider. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Micropos Medical AB (MPOS)：医療機器：M&Aディール及び事業提携情報
    Summary Micropos Medical AB (Micropos Medical) is a medical device company. The company develops technologies that enhance the precision in radiotherapy of cancer including hypofractionation and stereotactic radio surgery (SRS) and stereotactic body radiotherapy (SBRT). Its products include RayPilot …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆